Literature DB >> 3542950

The effect of quinolone antibacterials on the gastrointestinal flora compared with that of other antibacterials.

D S Reeves.   

Abstract

Although there is limited information on some of the newer quinolones it is likely that all such agents have a similar effect on the faecal flora. Ciprofloxacin seems to be best studied, and typical changes include regular and complete suppression of the enterobacteria and a slight diminution of enterococci. Total counts of anaerobic flora remain virtually unchanged, although small reductions have been noted in some studies for bacteroids, anaerobic cocci, fusobacteria and anaerobic non-sporing Gram-positive bacilli. Overgrowth of yeasts was not seen except when administration was prolonged. The results so far suggest that the newer quinolones will have a useful role in selective gut decontamination, the prevention of reinfection of the urinary tract, and the treatment of intestinal infection. Such early clinical results as have been published confirm this view. Of the other antibacterial agents discussed only some recent cephalosporins (cefotaxime, ceftazidime), aztreonam, cotrimoxazole and aminoglycosides have effects on the faecal flora similar to those of the newer quinolones. The remaining agents either have little or no effect or produce changes, such as a marked reduction in anaerobic flora, which are generally considered to be undesirable.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3542950     DOI: 10.1093/jac/18.supplement_d.89

Source DB:  PubMed          Journal:  J Antimicrob Chemother        ISSN: 0305-7453            Impact factor:   5.790


  11 in total

Review 1.  Infectious diarrhoea.

Authors:  C P Conlon; T E Peto
Journal:  Int J Colorectal Dis       Date:  1990-12       Impact factor: 2.571

2.  In vitro activity and mode of action of fluoroquinolones.

Authors:  L Verbist
Journal:  Pharm Weekbl Sci       Date:  1987-12-11

3.  Treatment with fluoroquinolones or with beta-lactam-beta-lactamase inhibitor combinations is a risk factor for isolation of extended-spectrum-beta-lactamase-producing Klebsiella species in hospitalized patients.

Authors:  Kenneth M Wener; Vered Schechner; Howard S Gold; Sharon B Wright; Yehuda Carmeli
Journal:  Antimicrob Agents Chemother       Date:  2010-03-08       Impact factor: 5.191

Review 4.  Fluoroquinolone antibiotics. Microbiology, pharmacokinetics and clinical use.

Authors:  J H Paton; D S Reeves
Journal:  Drugs       Date:  1988-08       Impact factor: 9.546

Review 5.  Use of the quinolones for the prophylaxis and therapy of infections in immunocompromised hosts.

Authors:  G Maschmeyer
Journal:  Drugs       Date:  1993       Impact factor: 9.546

6.  Multiple-dose pharmacokinetics of sparfloxacin and its influence on fecal flora.

Authors:  M Ritz; H Lode; M Fassbender; K Borner; P Koeppe; C E Nord
Journal:  Antimicrob Agents Chemother       Date:  1994-03       Impact factor: 5.191

7.  Prevention of febrile neutropenia: use of prophylactic antibiotics.

Authors:  M Cullen; S Baijal
Journal:  Br J Cancer       Date:  2009-09       Impact factor: 7.640

8.  Ciprofloxacin and norfloxacin for selective decontamination in patients with severe granulocytopenia.

Authors:  G Maschmeyer; E Haralambie; W Gaus; W Kern; A W Dekker; H G De Vries-Hospers; W Sizoo; W König; F Gutzler; S Daenen
Journal:  Infection       Date:  1988 Mar-Apr       Impact factor: 3.553

9.  An uncooked vegan diet shifts the profile of human fecal microflora: computerized analysis of direct stool sample gas-liquid chromatography profiles of bacterial cellular fatty acids.

Authors:  R Peltonen; W H Ling; O Hänninen; E Eerola
Journal:  Appl Environ Microbiol       Date:  1992-11       Impact factor: 4.792

10.  Norfloxacin binds to human fecal material.

Authors:  C Edlund; L Lindqvist; C E Nord
Journal:  Antimicrob Agents Chemother       Date:  1988-12       Impact factor: 5.191

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.